Fox Run Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,522
Closed -$297K 1347
2026
Q1
$297K Buy
+26,522
New +$331K 0.05% 623
2025
Q4
Sell
-42,690
Closed -$542K 1314
2025
Q3
$542K Buy
+42,690
New +$619K 0.08% 463
2024
Q3
Sell
-8,552
Closed -$213K 1149
2024
Q2
$213K Sell
8,552
-16,121
-65% -$462K 0.04% 660
2024
Q1
$819K Buy
+24,673
New +$843K 0.18% 198
2022
Q1
Sell
-3,809
Closed -$213K 735
2021
Q4
$213K Buy
+3,809
New +$209K 0.13% 349
2021
Q3
Sell
-5,702
Closed -$361K 647
2021
Q2
$361K Buy
5,702
+2,549
+81% +$168K 0.33% 112
2021
Q1
$201K Buy
+3,153
New +$183K 0.36% 175
2020
Q1
Sell
-9,586
Closed -$542K 390
2019
Q4
$542K Buy
+9,586
New +$534K 0.44% 35
2019
Q2
Sell
-10,066
Closed -$499K 653
2019
Q1
$499K Buy
+10,066
New +$443K 0.28% 102
2018
Q4
Sell
-9,251
Closed -$349K 772
2018
Q3
$349K Buy
+9,251
New +$385K 0.15% 300
2017
Q1
Sell
-7,600
Closed -$439K 771
2016
Q4
$439K Buy
+7,600
New +$449K 0.23% 169

Other funds holding XRAY

Fox Run Management's XRAY Position: Q2 2026 in Review

Fox Run Management sold out of Dentsply Sirona (XRAY) in Q2 2026, closing a stake of 26,522 shares — an estimated $297K sold.

Fox Run Management first reported a position in XRAY in Q4 2016 and held it in 11 quarters. The position peaked at $819K in Q1 2024. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Fox Run Management reported no remaining Dentsply Sirona position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 26,522 Dentsply Sirona shares in Q2 2026, an estimated $297K.
  • Fox Run Management first reported a position in Dentsply Sirona in Q4 2016 and held it in 11 quarters.
  • Fox Run Management's Dentsply Sirona position peaked at $819K in Q1 2024.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.